Annual report
7716.TEDINET S100VFKM
Period2024-01-01 → 2024-12-31
Filed2025-03-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥77.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥59.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥48.7bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥33.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥14.6bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥14.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥17.3bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.2bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.6bn | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥13.7bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥28.8bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.5bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.5bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥158.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥140.8bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥102.6bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥94.5bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥82.5bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.1bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥27.6bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥121.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥113.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥91.0bn | at 2022-12-31d | Cons. | Net assets |
| Net assets / equity | ¥82.9bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥76.3bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥31.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥35.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥31.6bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥30.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥15.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.8bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9.2bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.3bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥599m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.1bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.7bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥101.37 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥267.62 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.48 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.49 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥101.06 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥266.87 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥145.11 | 2022-01-01 → 2022-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥74.34 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,430.58 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,322.75 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,065.57 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥959.59 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥877.95 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.1% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,180 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 2,049 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 1,478 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 1,239 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 1,184 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥34.3bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥36.7bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥34.4bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥32.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥25.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥9.0bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥10.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥11.4bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.8bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.6bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥15.6bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥6.2bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥12.1bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥11.8bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥102.1bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥95.1bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥77.1bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥71.6bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥65.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥23.1bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥16.3bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥79.0bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥78.8bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥69.9bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥64.6bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥61.8bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥16.2bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥10.7bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥73.79 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥141.8 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.22 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.97 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.48 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.57 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥141.41 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.88 | 2022-01-01 → 2022-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.79 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥54.37 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥52 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2022-01-01 → 2022-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥930.73 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥919.68 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥817.09 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥746.98 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥710.8 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.5% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.3% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.0% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.3% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 93,418,200 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,100 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 1,060 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,004 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 906 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 869 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 79
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥515m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥214m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥214m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥66.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥5.7bn |
| DCI Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥80m |
| DCI Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| DCI Productsreportable segment | employees | at 2024-12-31 | 389 pure |
| DCI Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥19.5bn |
| DCI Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥19.5bn |
| DCI Productsreportable segment | segment assets | at 2024-12-31 | ¥46.8bn |
| DCI Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥90m |
| Dental Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| Dental Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥2.0bn |
| Dental Productsreportable segment | employees | at 2024-12-31 | 994 pure |
| Dental Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥46.7bn |
| Dental Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥46.5bn |
| Dental Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥214m |
| Dental Productsreportable segment | segment assets | at 2024-12-31 | ¥35.2bn |
| Dental Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥17.1bn |
| Industrial Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥610m |
| Industrial Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥446m |
| Industrial Productsreportable segment | employees | at 2024-12-31 | 240 pure |
| Industrial Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Industrial Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Industrial Productsreportable segment | segment assets | at 2024-12-31 | ¥8.2bn |
| Industrial Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥825m |
| Surgical Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥506m |
| Surgical Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥129m |
| Surgical Productsreportable segment | employees | at 2024-12-31 | 147 pure |
| Surgical Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥4.3bn |
| Surgical Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥4.3bn |
| Surgical Productsreportable segment | segment assets | at 2024-12-31 | ¥1.7bn |
| Surgical Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.3bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥4.1bn |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥3.7bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥77.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥77.0bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥214m |
| —segment total | segment assets | at 2024-12-31 | ¥91.9bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥20.2bn |
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥1.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥559m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥57.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥5.5bn |
| DCI Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥194m |
| DCI Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥224m |
| DCI Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥4.0bn |
| DCI Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥4.0bn |
| DCI Productsreportable segment | segment assets | at 2023-12-31 | ¥41.2bn |
| DCI Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥534m |
| Dental Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Dental Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.7bn |
| Dental Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥44.4bn |
| Dental Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥44.4bn |
| Dental Productsreportable segment | segment assets | at 2023-12-31 | ¥28.9bn |
| Dental Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥17.2bn |
| Industrial Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥641m |
| Industrial Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥400m |
| Industrial Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥7.6bn |
| Industrial Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥7.6bn |
| Industrial Productsreportable segment | segment assets | at 2023-12-31 | ¥9.9bn |
| Industrial Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Surgical Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥616m |
| Surgical Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥96m |
| Surgical Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥3.8bn |
| Surgical Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥3.8bn |
| Surgical Productsreportable segment | segment assets | at 2023-12-31 | ¥3.6bn |
| Surgical Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.9bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥4.7bn |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥59.7bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥59.7bn |
| —segment total | segment assets | at 2023-12-31 | ¥83.7bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥19.7bn |
| Dental Productsreportable segment | employees | at 2024-12-31 | 539 pure |
| Industrial Productsreportable segment | employees | at 2024-12-31 | 108 pure |
| Surgical Productsreportable segment | employees | at 2024-12-31 | 134 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,700
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)株式会社めぶきフィナンシャルグループ | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)主要取引金融機関であり、資金調達や営業情報の提供を受けており、同社グループとの良好な取引関係を維持・強化するため。 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)株式会社松風 | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)有 | |
| Footnotes specified investment shares held for purposes other than pure investment reporting company (text) | CurrentYearInstant_Row1Member | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |